Top

Gepubliceerd in:

07-05-2023

Post-discharge health assessment in survivors of coronavirus disease: a time-point analysis of a prospective cohort study

Auteurs: Ramin Sami, Sina Arabi, Khojasteh Ghasemi, Mahsa Akafzadeh, Sara Ebrahimi, Arash Toghyani, Razieh Mahvari, Reza Moayednia, Seyed Amir Dadkhahi, Sara Sadeghi, Hamid Reza Marateb, Peyman Adibi, Aryan Kavosh, Marjan Mansourian

Gepubliceerd in: Quality of Life Research | Uitgave 9/2023

Abstract

Purpose

The objective of this study was to quantitatively evaluate psychological and quality of life-related complications at three months following discharge in hospitalized coronavirus disease 2019 (COVID-19) patients during the pandemic in Iran.

Methods

In this time-point analysis of prospective cohort study data, adult patients hospitalized with symptoms suggestive of COVID-19 were enrolled. Patients were stratified in analyses based on severity. The primary outcomes consisted of psychological problems and pulmonary function tests (PFTs) in the three months following discharge, with Health-related quality of life (HRQoL) as the secondary outcome. Exploratory predictors were determined for both primary and secondary outcomes.

Results

283 out of 900 (30%) eligible patients were accessible for the follow-up assessment and included in the study. The mean age was 53.65 ± 13.43 years, with 68% experiencing a severe disease course. At the time of the final follow-up, participants still reported persistent symptoms, among which fatigue, shortness of breath, and cough were the most common. Based on the regression-adjusted analysis, lower levels of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio was associated with higher levels of depression (standardized β = − 0.161 (SE = 0.042), P = 0.017) and stress levels (standardized β =− 0.110 (SE = 0.047), P = 0.015). Furthermore, higher levels of anti-SARS-CoV-2 immunoglobulin-M (IgM) were associated with significantly lower levels of depression (standardized β = − 0.139 (SE = 0.135), P = 0.031).

Conclusions

There is an association between lung damage during COVID-19 and the reduction of pulmonary function for up to three months from acute infection in hospitalized patients. Varying degrees of anxiety, depression, stress, and low HRQoL frequently occur in patients with COVID-19. More severe lung damage and lower COVID-19 antibodies were associated with lower levels of psychological health.

vorige artikel Measuring glaucoma quality of life in an Asian population using item banking: psychometric evaluation and computerized adaptive testing simulations

volgende artikel Health-related quality of life before and during the COVID-19 pandemic in Switzerland: a cross-sectional study

Alleen toegankelijk voor geautoriseerde gebruikers

Lee, A. (2020). Wuhan novel coronavirus (COVID-19): Why global control is challenging? Public Health, 179, A1-2.CrossRefPubMed

Xiang, Y. T., Yang, Y., Li, W., et al. (2020). Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry, 7(3), 228–229.CrossRefPubMedPubMedCentral

Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J., & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924.CrossRefPubMedPubMedCentral

Gamberini, L., Mazzoli, C. A., Sintonen, H., Colombo, D., Scaramuzzo, G., Allegri, D., Tonetti, T., Zani, G., Capozzi, C., Giampalma, E., Agnoletti, V., Becherucci, F., Bertellini, E., Castelli, A., Cappellini, I., Cavalli, I., Crimaldi, F., Damiani, F., Fusari, M., … Spadaro, S. (2021). ICU-RER COVID-19 Collaboration. Quality of life of COVID-19 critically ill survivors after ICU discharge: 90 days follow-up. Quality of Life Research, 30(10), 2805–2817. https://doi.org/10.1007/s11136-021-02865-7CrossRefPubMedPubMedCentral

Mirzaei, N., Jahanian Sadatmahalleh, S., Bahri Khomami, M., Moini, A., & Kazemnejad, A. (2021). Sexual function, mental health, and quality of life under strain of COVID-19 pandemic in Iranian pregnant and lactating women: A comparative cross-sectional study. Health and Quality of Life Outcomes, 19, 66.CrossRefPubMedPubMedCentral

Montazeri, A.L.I., Tavousi, M., Rakhshani, F., Azin, S.A., Jahangiri, K., Ebadi, M., Naderimagham, S., Solimanian, A., Sarbandi, F., Motamedi, A., & Sistani, M.M.N. (2014). Health Literacy for Iranian Adults (HELIA): Development and psychometric properties. Payesh (Health Monitor), 13(5), 589–599. http://payeshjournal.ir/browse.php?a_id=279&sid=1&slc_lang=en

Sami, R., Soltaninejad, F., Amra, B., Naderi, Z., Haghjooy Javanmard, S., Iraj, B., Haji Ahmadi, S., Shayganfar, A., Dehghan, M., Khademi, N., Sadat Hosseini, N., Mortazavi, M., Mansourian, M., Mañanas, M. A., Marateb, H. R., & Adibi, P. (2020). A one-year hospital-based prospective COVID-19 open-cohort in the Eastern Mediterranean region: The Khorshid COVID Cohort (KCC) study. PLoS ONE, 15(11), e0241537.CrossRefPubMedPubMedCentral

Li, J., Zhang, K., Bao, J., Yang, J., & Wu, C. (2022). Potential mechanism of action of Jing Fang Bai Du San in the treatment of COVID-19 using docking and network pharmacology. International Journal of Medical Sciences, 19(2), 213–224.CrossRefPubMedPubMedCentral

Ai, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., et al. (2020). Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology, 296, 32–40.CrossRef

10.

Sami, R., Soltaninejad, F., Shayganfar, A., Mirfendereski, S., Mansourian, M., Khademi, N., Dehghan, M., Khorrami, Z., Jalali, S., & Mokhtari, Z. (2022). Severity of disease and COVID-19 complications during hospital stay: A prospective cohort study. Archives of Iranian Medicine, 25(6), 383–393.CrossRefPubMed

11.

Montazeri, A., Goshtasebi, A., Vahdaninia, M., & Gandek, B. (2005). The Short Form Health Survey (SF-36): Translation and validation study of the Iranian version. Quality of Life Research, 14(3), 875–882. https://doi.org/10.1007/s11136-004-1014-5CrossRefPubMed

12.

Ell, K., Unützer, J., Aranda, M., Sanchez, K., & Lee, P.-J. (2005). Routine PHQ-9 depression screening in home health care: Depression, prevalence, clinical and treatment characteristics and screening implementation. Home Health Care Services Quarterly, 24, 1–19.CrossRefPubMedPubMedCentral

13.

Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395–404. https://doi.org/10.1023/a:1012552211996CrossRefPubMed

14.

Nguyen, H. C., Nguyen, M. H., Do, B. N., et al. (2020). People with suspected covid-19 symptoms were more likely depressed and had lower health-related quality of life: the potential benefit of health literacy. Journal of Clinical Medicine, 9(4), 965. https://doi.org/10.3390/jcm9040965CrossRefPubMedPubMedCentral

15.

Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The patient health questionnaire somatic, anxiety, and depressive symptom scales: A systematic review. General Hospital Psychiatry, 32(4), 345–359. https://doi.org/10.1016/j.genhosppsych.2010.03.006CrossRefPubMed

16.

Tapak, L., Cheraghi, F., Sadeghi, A., Shirmohammadi, N., & Feizybarnaji, A. (2022). Usefulness of the SF-36 Health Survey questionnaire in screening for health-related quality of life among parents of children with cancer: Latent profile analysis. Journal of Preventive Medicine and Hygiene, 63(1), 142–151. https://doi.org/10.15167/2421-4248/jpmh2022.63.1.2279CrossRef

17.

Singh, D., Agusti, A., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Criner, G. J., Frith, P., Halpin, D. M. G., Han, M., López Varela, M. V., Martinez, F., Montes de Oca, M., Papi, A., Pavord, I. D., Roche, N., Sin, D. D., Stockley, R., Vestbo, J., … Vogelmeier, C. (2019). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. European Respiratory Journal, 53(5), 1900164. https://doi.org/10.1183/13993003.00164-2019CrossRefPubMed

18.

Zhao, Y. M., Shang, Y. M., Song, W. B., et al. (2020). Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine, 25, 100463.CrossRefPubMedPubMedCentral

19.

Shah, A. S., Wong, A. W., Hague, C. J., et al. (2020). A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. https://doi.org/10.1136/thoraxjnl-2020-216308CrossRefPubMed

20.

Carfì, A., Bernabei, R., & Landi, F. (2020). Gemelli against COVID-19 post-acute care study group persistent symptoms in patients after acute COVID-19. JAMA, 324(6), 603–605. https://doi.org/10.1001/jama.2020.12603CrossRefPubMedPubMedCentral

21.

Barman, M. P., Rahman, T., Bora, K., & Borgohain, C. (2020). COVID-19 pandemic and its recovery time of patients in India: A pilot study. Diabetes & Metabolic Syndrome, 14(5), 1205–1211. https://doi.org/10.1016/j.dsx.2020.07.004CrossRef

22.

Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y., & Dong, W. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection, 27(1), 89–95. https://doi.org/10.1016/j.cmi.2020.09.023CrossRefPubMed

23.

Arnold, D. T., Hamilton, F. W., Milne, A., Morley, A. J., Viner, J., Attwood, M., Noel, A., Gunning, S., Hatrick, J., Hamilton, S., Elvers, K. T., Hyams, C., Bibby, A., Moran, E., Adamali, H. I., Dodd, J. W., Maskell, N. A., & Barratt, S. L. (2021). Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax, 76(4), 399–401. https://doi.org/10.1136/thoraxjnl-2020-216086CrossRefPubMed

24.

Huang, L., Yao, Q., Gu, X., Wang, Q., Ren, L., Wang, Y., Hu, P., Guo, L., Liu, M., Xu, J., Zhang, X., Qu, Y., Fan, Y., Li, X., Li, C., Yu, T., Xia, J., Wei, M., Chen, L., … Cao, B. (2021). 1-year outcomes in hospital survivors with COVID-19: A longitudinal cohort study. Lancet, 398(10302), 747–758. https://doi.org/10.1016/S0140-6736(21)01755-4CrossRefPubMedPubMedCentral

25.

Hui, D. S., Wong, K. T., Ko, F. W., Tam, L. S., Chan, D. P., Woo, J., & Sung, J. J. (2005). The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest, 128(4), 2247–2261. https://doi.org/10.1378/chest.128.4.2247CrossRefPubMed

26.

Ngai, J. C., Ko, F. W., Ng, S. S., To, K. W., Tong, M., & Hui, D. S. (2010). The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology, 15(3), 543–550. https://doi.org/10.1111/j.1440-1843.2010.01720.xCrossRefPubMedPubMedCentral

27.

Hui, D. S., Joynt, G. M., Wong, K. T., Gomersall, C. D., Li, T. S., Antonio, G., Ko, F. W., Chan, M. C., Chan, D. P., Tong, M. W., Rainer, T. H., Ahuja, A. T., Cockram, C. S., & Sung, J. J. (2005). Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax, 60(5), 401–409. https://doi.org/10.1136/thx.2004.030205CrossRefPubMedPubMedCentral

28.

Su, M. C., Hsieh, Y. T., Wang, Y. H., Lin, A. S., Chung, Y. H., & Lin, M. C. (2007). Exercise capacity and pulmonary function in hospital workers recovered from severe acute respiratory syndrome. Respiration, 74, 511–516.CrossRefPubMed

29.

Tsai, L. K., Hsieh, S. T., Chao, C. C., et al. (2004). Neuromuscular disorders in severe acute respiratory syndrome. Archives of Neurology, 61, 1669–1673.CrossRefPubMed

30.

Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., Kang, L., Guo, L., Liu, M., Zhou, X., Luo, J., Huang, Z., Tu, S., Zhao, Y., Chen, L., Xu, D., Li, Y., Li, C., Peng, L., … Cao, B. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet, 397(10270), 220–232. https://doi.org/10.1016/S0140-6736(20)32656-8CrossRefPubMedPubMedCentral

31.

Lerum, T. V., Aaløkken, T. M., Brønstad, E., Aarli, B., Ikdahl, E., Lund, K. M. A., Durheim, M. T., Rodriguez, J. R., Meltzer, C., Tonby, K., Stavem, K., Skjønsberg, O. H., Ashraf, H., & Einvik, G. (2021). Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. European Respiratory Journal, 57(4), 2003448. https://doi.org/10.1183/13993003.03448-2020CrossRefPubMed

32.

Ramani, C., Davis, E. M., Kim, J. S., Provencio, J. J., Enfield, K. B., & Kadl, A. (2021). Post-ICU COVID-19 Outcomes: A case series. Chest, 159(1), 215–218. https://doi.org/10.1016/j.chest.2020.08.2056CrossRefPubMed

33.

Guler, S. A., Ebner, L., Aubry-Beigelman, C., Bridevaux, P. O., Brutsche, M., Clarenbach, C., Garzoni, C., Geiser, T. K., Lenoir, A., Mancinetti, M., Naccini, B., Ott, S. R., Piquilloud, L., Prella, M., Que, Y. A., Soccal, P. M., von Garnier, C., & Funke-Chambour, M. (2021). Pulmonary function and radiological features 4 months after COVID-19: First results from the national prospective observational Swiss COVID-19 lung study. European Respiratory Journal, 57(4), 2003690. https://doi.org/10.1183/13993003.03690-2020CrossRefPubMed

34.

de Graaf, M. A., Antoni, M. L., Ter Kuile, M. M., Arbous, M. S., Duinisveld, A. J. F., Feltkamp, M. C. W., Groeneveld, G. H., Hinnen, S. C. H., Janssen, V. R., Lijfering, W. M., Omara, S., Postmus, P. E., Ramai, S. R. S., Rius-Ottenheim, N., Schalij, M. J., Schiemanck, S. K., Smid, L., Stöger, J. L., Visser, L. G., … Roukens, A. H. E. (2021). Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach. EClinicalMedicine, 32, 100731. https://doi.org/10.1016/j.eclinm.2021.100731CrossRefPubMedPubMedCentral

35.

Bellan, M., Soddu, D., Balbo, P. E., Baricich, A., Zeppegno, P., Avanzi, G. C., Baldon, G., Bartolomei, G., Battaglia, M., Battistini, S., Binda, V., Borg, M., Cantaluppi, V., Castello, L. M., Clivati, E., Cisari, C., Costanzo, M., Croce, A., Cuneo, D., … Pirisi, M. (2021). Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Network Open, 4(1), e2036142. https://doi.org/10.1001/jamanetworkopen.2020.36142CrossRefPubMedPubMedCentral

36.

Gamberini, L., Mazzoli, C. A., Prediletto, I., Sintonen, H., Scaramuzzo, G., Allegri, D., Colombo, D., Tonetti, T., Zani, G., Capozzi, C., Dalpiaz, G., Agnoletti, V., Cappellini, I., Melegari, G., Damiani, F., Fusari, M., Gordini, G., Laici, C., Lanza, M. C., … Spadaro, S. (2021). Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respiratory Medicine, 189, 106665. https://doi.org/10.1016/j.rmed.2021.106665CrossRefPubMedPubMedCentral

37.

Xie, Y., Xu, E., & Al-Aly, Z. (2022). Risks of mental health outcomes in people with covid-19: Cohort study. BMJ, 16(376), e068993. https://doi.org/10.1136/bmj-2021-068993CrossRef

38.

Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry, 7(7), 611–627. https://doi.org/10.1016/S2215-0366(20)30203-0CrossRefPubMedPubMedCentral

39.

Taquet, M., Geddes, J. R., Husain, M., Luciano, S., & Harrison, P. J. (2021). 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry, 8(5), 416–427. https://doi.org/10.1016/S2215-0366(21)00084-5CrossRefPubMedPubMedCentral

40.

Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., Calcuttawala, K., Vest, R. T., Berdnik, D., Lu, N., Hahn, O., Gate, D., McNerney, M. W., Channappa, D., Cobos, I., … Wyss-Coray, T. (2021). Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature, 595(7868), 565–571. https://doi.org/10.1038/s41586-021-03710-0CrossRefPubMedPubMedCentral

41.

Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V., Pesenti, A., Peyvandi, F., & Tripodi, A. (2020). Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. Journal of Thrombosis and Haemostasis, 18(7), 1738–1742. https://doi.org/10.1111/jth.14850CrossRefPubMedPubMedCentral

42.

Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Brünink, S., Greuel, S., Lehmann, M., Hassan, O., Aschman, T., Schumann, E., Chua, R. L., Conrad, C., Eils, R., Stenzel, W., Windgassen, M., … Heppner, F. L. (2021). Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nature Neuroscience, 24(2), 168–175. https://doi.org/10.1038/s41593-020-00758-5CrossRefPubMed

43.

Townsend, E. (2020). COVID-19 policies in the UK and consequences for mental health. Lancet Psychiatry, 7(12), 1014–1015. https://doi.org/10.1016/S2215-0366(20)30457-0CrossRefPubMedPubMedCentral

44.

Goodwin, R. D., Chuang, S., Simuro, N., Davies, M., & Pine, D. S. (2007). Association between lung function and mental health problems among adults in the United States: Findings from the first national health and nutrition examination survey. American Journal of Epidemiology, 165(4), 383–388. https://doi.org/10.1093/aje/kwk026CrossRefPubMed

45.

O’Leary, C. J., Wilson, C. B., Hansell, D. M., Cole, P. J., Wilson, R., & Jones, P. W. (2002). Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respiratory Medicine, 96(9), 686–692. https://doi.org/10.1053/rmed.2002.1330CrossRefPubMed

46.

Liu, L., To, K. K., Chan, K. H., Wong, Y. C., Zhou, R., Kwan, K. Y., Fong, C. H., Chen, L. L., Choi, C. Y., Lu, L., Tsang, O. T., Leung, W. S., To, W. K., Hung, I. F., Yuen, K. Y., & Chen, Z. (2020). High neutralizing antibody titer in intensive care unit patients with COVID-19. Emerging Microbes & Infections, 9(1), 1664–1670. https://doi.org/10.1080/22221751.2020.1791738CrossRef

47.

Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., Coppi, A., Lucas, C., Silva, J., Oh, J. E., Song, E., Perotti, E. S., Zheng, N. S., Fischer, S., Campbell, M., & Ring, A. M. (2021). Diverse functional autoantibodies in patients with COVID-19. Nature, 595(7866), 283–288. https://doi.org/10.1038/s41586-021-03631-yCrossRefPubMed

Titel: Post-discharge health assessment in survivors of coronavirus disease: a time-point analysis of a prospective cohort study
Auteurs: Ramin Sami
Sina Arabi
Khojasteh Ghasemi
Mahsa Akafzadeh
Sara Ebrahimi
Arash Toghyani
Razieh Mahvari
Reza Moayednia
Seyed Amir Dadkhahi
Sara Sadeghi
Hamid Reza Marateb
Peyman Adibi
Aryan Kavosh
Marjan Mansourian
Publicatiedatum: 07-05-2023
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 9/2023
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-023-03415-z

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Purpose

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 9/2023

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary

Caregivers of patients with malignant pleural mesothelioma: who provides care, what care do they provide and what burden do they experience?

Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503

Health-related quality of life 12 years after injury: prevalence and predictors of outcomes in a cohort of injured Māori

Patients’ perspectives on irritable bowel syndrome: a qualitative analysis based on social media in China

A comparison of the Child Health Utility 9D and the Health Utilities Index for estimating health utilities in pediatric inflammatory bowel disease